Outline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks

Size: px
Start display at page:

Download "Outline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks"

Transcription

1 Outline Clinicopathologic Conference RAIN 2017 Case Presenter: Scott Caganap, MD Clinical Discussant: Gil Rabinovici, MD Pathology Discussant: Lea Grinberg, MD, PhD Case Presentation 1. History and Exam 2. Expert Opinion 3. Ancillary Testing 4. Final Diagnosis? Pathology Presentation Closing Remarks Case Presentation Year 1 Difficulty fixing up cars 68 year-old left-handed man with progressive cognitive impairment Accompanied by his wife who does most of the reporting Year 2 Year 3 Year 4 Trouble understanding his wife in conversation Hearing aid no improvement Repeating conversations, word-finding difficulty, substitute/mispronounce words Paucity of speech (down 25%), spoke with softer voice Progressive difficulty with familiar tasks, stopped driving Speech output down 80%, difficulty expressing himself hand motions No longer pursued hobbies, quit working, needed encouragement to keep up his hygiene Increased sleep, daytime naps Lacked insight, content mood Year 5 Nearly mute, unable to read or write Excessive eating, weight gain, stuff large amounts of food in his mouth Walk outside in only underwear Repetitively paced in his yard in a particular pattern 68 year-old left-handed man with progressive cognitive impairment 1

2 Review of Systems Cognition: No fluctuations in cognition or level of arousal Unclear if memory is an issue because he speaks so rarely Does not get lost in familiar environments No issues recognizing his family, but may not recognize former co-workers occasionally Review of Systems Psychiatric: Approximately 10 years ago, he had a recurrent delusion in which he suspected his wife of infidelity, but this resolved with marriage counseling No illusions, misperceptions, or hallucinations Review of Systems Neurologic: No changes in vision Difficulty swallowing (pills, large solids); coughs during meals Intermittently kicked his legs while sleeping Generally slower movements No tremor, weakness, incoordination, or recurrent falls Occasional urinary incontinence Personal History PMH: BPH s/p laser surgery MEDS: tamsulosin, NKDA FH: two healthy sons; biological family not known Social History: Raised in foster care. Lost foster parents at a young age. Grew up in central California. Completed the twelfth grade without difficulty. Most recently worked a part-time job as a dishwasher. Previously employed as a mechanic at an auto shop. Rare alcohol consumption. No tobacco or illicit drug use. 2

3 Examination General: Normal vital signs, 137 lbs., 5 7 Cooperative, well-groomed Alert, DSF 4 Mental Status Exam Flat affect, slow to respond Unable to spell WORLD backward, DSB 0 Oriented to self, city, month, and date, but not season, year, or place Word registration 3/3, recall 0/3 Mental Status Exam Sparse speech, up to 4-word sentences, grammatically correct Used hand gestures when attempting to speak Named only a few simple objects Can repeat a simple sentence Unable to perform multi-step tasks Mental Status Exam Unable to copy intersecting pentagons Could not pantomime blow-a-kiss or whistle Unable to perform 3-step hand movement task (Luria test) on both sides MMSE 8/30 3

4 Cranial Nerve Exam VFF, no extinction to DSS PERRLA EOMI except for limitation in up-gaze, gaze impersistence Normal saccades, no nystagmus Cranial Nerve Exam Mild hypophonia and guttural dysarthria Moderate hypomimia, full facial strength Mildly diminished hearing bilaterally Symmetric palate elevation Normal tongue movements, no fasciculation Motor Exam Occasional BUE fasciculation Paratonia in all extremities Slowing of movements in all extremities (R>L) Reduced amplitude finger/foot tapping No postural or rest tremor Full strength Coordination Exam Intention tremor during FNF testing on R No dysmetria Unable to perform RAMs 4

5 Reflex Exam R palmar grasp Reflex Exam R palmomental & rooting reflex Snout reflex Sensory Exam Normal sensation to all modalities No extinction to DSS Normal stereognosis No instability during Romberg testing Slow, cautious Gait Exam Short-stride length Decreased arm-swing bilaterally One step backwards during retropulsion testing 5

6 Expert Opinion What are your thoughts Dr. Rabinovici? Differential Diagnosis? Further Workup? Leading Diagnosis? Expected Underlying Pathology? Clinicopathological Conference: 68 year-old with 5 years of cognitive and behavioral decline Gil Rabinovici, M.D. Associate Professor of Neurology, UCSF 50 th Annual Recent Advances in Neurology February 10, 2017 Disclosures Research support Avid Radiopharmaceuticals/Eli Lilly, GE Healthcare, Piramal Imaging NIH (NIA, NINDS, NCATS), American College of Radiology, Alzheimer s Association, Tau Consortium, Association for Frontotemporal Degeneration, Michael J Fox Foundation Consulting/honoraria Eisai, Genentech, Lundbeck, Merck, Putnam, Roche Approach to Patient with Cognitive Complaints HPI probes cognitive domains Memory: misplacing items, repetitive questions, missing appointments or bills, remote memory Visuospatial: navigation, spatial relationships, object and face recognition Language: production and comprehension, motor speech, reading and writing Executive: decision-making, judgment, multi-tasking, concentration/focus Behavior: personality changes, depression, anxiety, apathy, disinhibition, psychosis Motor First or early symptoms particularly helpful PMH, Meds, FH, SH may offer valuable clues 6

7 Approach to Patient with Cognitive Complaints Mental Status exam and neuropsychological testing Better define cognitive domains Physical neurological exam Cranial nerves Motor: UMN/LMN, parkinsonism Sensory loss Ataxia Gait Approach to Patient with Cognitive Complaints Labs: exclude treatable metabolic or infectious causes Mandatory Chem 20, CBC, B12, TSH Discretionary RPR/FTA-ABS, HIV, homocysteine/methylmalonic acid, LP, rheumatologic, paraneoplastic, heavy metals, etc. Imaging (MRI preferred) Exclude tumor, SDH, NPH, etc. Evaluate for vascular lesions Pattern of atrophy From Clinical Syndrome to Pathology Aβ Tau TDP-43 α-synuclein Common Causes of Neurodegenerative Dementia Disease Protein Anatomy Early Sxs Neuropsych AD Aβ, tau Medial temporal Posterior temporoparietal DLB FTD α-synuclein Aβ Tau TDP-43 FUS Frontal Occipital/temporal Basal ganglia Brainstem Frontal Anterior temporal VascD N/A Often frontal predominant (but variable) Memory loss, spatial disorientation Behavior spared Parkinsonism, RBD, Psychosis, fluctuations Disinihibition, apathy, personality changes Aphasia, executive dysfunction Motor-neuron disease Often dysexecutive, memory, visuospatial, behavioral Episodic memory Visuospatial Dysexecutive Visuospatial Dysexecutive Memory relatively spared Dysexecutive Memory may be spared Visuospatial usually spared Often executive functions worst, though variable 7

8 History: Cognitive Symptoms First symptom: difficulty performing skilled tasks (e.g. car repairs) Executive, motor planning or output, procedural memory Language decline Difficulty understanding his wife comprehension, attention Decreased speech output, short sentences Mispronouncing words, soft voice, mutism - motor speech Repeating previous conversations Episodic memory, perseveration Unable to read or write: pervasive language deficits History: Behavioral Symptoms Apathetic! Loss of initiative, interest in hobbies, personal hygiene, hyper-somnolence Blissfully unaware Poor insight, not perturbed by deficits Repetitive motor behaviors, pacing Disinhibition Walking around in underwear Overeating Frontal Circuits: Cognition & Behavior Speech Production Networks Key nodes: inferior frontal gyrus (BA 44), supplementary motor area (SMA), caudate Executive Control Network Lateral, fronto-parietal Cognitive Seeley et al. J Neurosci Salience Network Medial, fronto-insular Social-emotional behavior T-score T-score T-score Aberrant Motor Behavior Apathy Disinhibition Rosen et al. Brain 2005 Key tracts: aslan tract (AT), superior longitudinal fasciculus (SLF), fronto-striatal Gorno-Tempini et al. Neurology 2006 Mandelli et al. Brain

9 Additional History Dysphagia Occasional urinary incontinence Delusion of marital infidelity 10 years ago, no hallucinations No sleep disturbance No major medical co-morbidities, Rx Family history unknown Exam: Pertinent Positives and Negatives Thin (5 7, 137 lbs.) despite over-eating Cognitively globally impaired (but knows exact date) Slow, apathetic, little speech output, orobuccal apraxia Digits forwards 4, backwards 0; working memory disproportionately affected vs. repetition Saccades intact; hypophonic, guttaral dysarthria UE fasciculations; mild hyper-reflexia, R Babinski Hypomimia, bradykinesia R>L, slow gait with decreased arm swing Intention tremor on R, no truncal or limb ataxia Case Summary Rabinovici et al., Continuum 2015 Chronic, progressive course and absence of co-morbidities consistent with primary neurodegenerative disease Cognitive: Early and disproportionate executive dysfunction and motor speech Behavior: Apathy > disinhibition, overeating Motor: UMN/LMN; mild extra-pyramidal Localization: Dorsolateral and dorsomedial prefrontal cortex, L>R UMN and C-spine LMN, basal ganglia 9

10 Common Causes of Neurodegenerative Dementia Disease Protein Anatomy Early Sxs Neuropsych AD Aβ, tau Medial temporal Parietal Frontal DLB FTD α-synuclein Aβ Tau TDP-43 FUS Frontal Occipital/temporal Brainstem Frontal Anterior temporal VascD N/A Often frontal predominant (but variable) Memory loss, spatial disorientation, social graces preserved Parkinsonism, RBD, Psychosis, fluctuations Disinihibition, apathy, personality changes, Aphasia, executive dysfunction Motor-neuron disease Often dysexecutive, memory, behavioral Episodic memory Visuospatial Dysexecutive Visuospatial Dysexecutive Memory relatively spared Dysexecutive Memory usually spared Visuospatial always spared Often executive functions worst, though variable Frontotemporal Dementia Family of clinicopathologic syndromes Progressive changes in behavior or language Neurodegeneration of frontal or anterior temporal lobes Common cause of pre-senile dementia 5% of all dementia, most common cause of early-onset dementia (<65 years) Incidence 3-4/10 5, prevalence 15-22/10 5 Even more common when include associated disorders ALS, HS, CBD, PSP, CTE Clinical Syndromes: FTD PSP CBD nfvppa bvftd svppa FTLD-ALS FTLD-TAU FTLD-FUS FTLD-TDP Pathology: FTLD MAPT Genes C9ORF72 PGRN Behavioral-Variant FTD: Clinical Criteria (3 of 6 for Possible bvftd ) Early behavioral disinhibition Early apathy or inertia - Early loss of emotional reactivity/sympathy and empathy Perseverative, stereotyped or compulsive/ritualistic behavior Hyper-orality and dietary changes - Executive-predominant cognitive dysfunction Rabinovici and Miller. CNS Drugs 2010 Rascovsky et al. Brain

11 Behavioral-Variant FTD: Clinical Criteria (3 of 6 for Possible bvftd ) Early behavioral disinhibition - +/- Early apathy or inertia - Early loss of emotional reactivity/sympathy and empathy - No Perseverative, stereotyped or compulsive/ritualistic behavior - Hyper-orality and dietary changes - Executive-predominant cognitive dysfunction perhaps early on, now too impaired to judge Atrophy Patterns in FTLD vs. AD Pathology-proven AD/FTLD vs. NC Distinct atrophy in AD and FTLD Common atrophy in AD and FTLD Rascovsky et al. Brain 2011 Rabinovici et al. AJADOD 2007 Amyloid vs. FDG-PET in Differential Diagnosis of AD vs. FTD AD (N=62, age 65, MMSE 22) FTD (N=45, age 65, MMSE 22) Amyloid (PIB) PET visual reads 90% sensitivity, 83% specificity Inter-rater agreement κ=0.96 FDG-PET visual reads 78% sensitivity*, 84% specificity Inter-rater agreement κ=0.72* 70 autopsy-proven cases PIB: Sensitivity 96%, Specificity 88% FDG: Sensitivity 88%, Specificity 89% * - p<0.05 vs. PIB Rabinovici et al. Neurology 2011 bvftd Probable or Definite Probable bvftd Meets criteria for possible bvftd Significant functional decline Frontal/anterior temporal pattern on MRI/FDG bvftd with definite FTLD pathology Histopathological evidence on bx/autopsy Presence of a known pathogenic mutation Exclusions Deficits better accounted for by other medical, neurological or psychiatric disorder Biomarkers strongly indicative of AD or other process Rascovsky et al. Brain

12 Primary Progressive Aphasia Progressive loss of language with relative preservation of other cognitive functions Non-fluent/agrammatic variant (nfvppa) Effortful speech, agrammatism, motor speech deficits Pathology: FTLD-Tau > FTLD-TDP Semantic variant (svppa) Fluent, grammatically correct speech with loss of word and object meaning Pathology: FTLD-TDP Logopenic variant (lvppa) Hesitant speech with word finding difficulty, poor repetition Pathology: AD Mesulam, Ann Neurol 1982 Gorno-Tempini et al. Neurology 2011 Progressive Supranuclear Palsy Richardson s Syndrome Vertical gaze palsies, postural instability with early falls, axial-predominant parkinsonism Highly specific but not sensitive at early stages Cognitive decline Executive dysfunction, slowed processing speed, impaired working memory Behavioral symptoms Apathy, depression, impulsivity Atypical phenotypes PSP-parkinsonism, pure akinesia with gait freezing (PAGF), nonfluent PPA, bvftd Clinical Phenotypes of Corticobasal Degeneration Corticobasal syndrome (CBS) Asymmetric limb rigidity/akinesia, dystonia, myoclonus Orobuccal/limb apraxia, cortical sensory loss, alien limb Frontal behavioral-spatial syndrome Executive dysfunction, behavior/personality changes, visuospatial deficits Nonfluent primary progressive aphasia Effortful speech, agrammatism, apraxia of speech PSP syndrome Symmetric, supranuclear gaze palsies, early falls Armstrong et al. Neurol 2013 FTLD-TAU Clinical Syndromes: FTD bvftd FTLD-ALS FTLD-FUS FTLD-TDP Pathology: FTLD MAPT Genes C9ORF72 PGRN Rabinovici and Miller. CNS Drugs

13 FTLD-tau Pick s PSP CBD FTLD-FUS Neuropathological Dx in Clinical bvftd UCSF Neurodegenerative Brain Bank, N=117 TDP-A TDP-B TDP-C FTLD-TDP DPR (C9ORF72) Courtesy of David Perry, Lea Grinberg & Bill Seeley None Predicting Pathology in bvftd: Clinical Pearls FTLD-tau: Not helpful FTDC criteria FTLD-TDP Delusions more common (and more severe on NPI) More signs of MND None with visual misperception FTLD-FUS No difference in 6 core FTDC features at presentation or throughout follow-up Frequency of meeting possible or probable FTDC criteria Parkinsonism Younger age at onset, presentation, and death More oral exploration More severe NPI anxiety, euphoria, apathy, disinhibition, aberrant motor, sleep disturbance, eating behavior Worse verbal memory and more design fluency repetitions FTD Autosomal Dominant Mutations Mutation C9orf72 MAPT GRN Age of DX Clinical MRI Unique clinical Neuropath bvftd, ALS FTD-ALS, (AD) Diffuse cortical, can be mild, thalamus, cerebellum ALS, psychiatric prodrome with slow progression FTLD-TDP B FTLD-TDP A FTLD-TDP (U) bvftd, PSP. CBS, (AD) Frontotemporal temporal > frontal Symmetry, addiction FTLD-Tau (usually 4R) bvftd, nfvppa, CBS, (AD) Asymmetric frontotemporal, parietal Asymmetric syndromes FTLD-TDP A 13

14 Genetic vs. Sporadic FTD Tau PET in FTD: [ 18 F]AV1451 Whitwell et al. Brain 2012 Spina et al. Neurology 2017 Final Conclusions Year 1 Difficulty fixing up cars Clinical dx: behavioral-variant FTD (with prominent language disturbance) Predicted pathology (in order of likelihood): 1. FTLD-TDP, type B; sporadic or C9ORF72 2. FTLD-TDP, type A/U 3. FTLD-Tau (Pick, PSP, CBD) less likely 4. AD unlikely to be primary pathology Year 2 Year 3 Year 4 Year 5 Trouble understanding his wife in conversation Hearing aid no improvement Repeating conversations, word-finding difficulty, substitute/mispronounce words Paucity of speech (down 25%), spoke with softer voice Progressive difficulty with familiar tasks, stopped driving Speech output down 80%, difficulty expressing himself hand motions No longer pursued hobbies, quit working, needed encouragement to keep up his hygiene Increased sleep, daytime naps Lacked insight, content mood Nearly mute, unable to read or write Excessive eating, weight gain, stuff large amounts of food in his mouth Walk outside in only underwear Repetitively paced in his yard in a particular pattern 68 year-old left-handed man with progressive cognitive impairment ROS Dysphagia Bradykinesia Incontinence 14

15 Ancillary Testing Basic serum studies including B12 and TFTs were unremarkable Year 1 Year 2 Difficulty fixing up cars Trouble understanding his wife in conversation Hearing aid no improvement MRI Brain: No mass lesions or ischemic changes Subtle generalized atrophy,? anterior predominance, no lateralization FDG-PET: global hypometabolism with sparing of bilateral occipital cortices and posterior cingulate Year 3 Year 4 Year 5 Repeating conversations, word-finding difficulty, substitute/mispronounce words Paucity of speech (down 25%), spoke with softer voice Progressive difficulty with familiar tasks, stopped driving Speech output down 80%, difficulty expressing himself hand motions No longer pursued hobbies, quit working, needed encouragement to keep up his hygiene Increased sleep, daytime naps Lacked insight, content mood Nearly mute, unable to read or write Excessive eating, weight gain, stuff large amounts of food in his mouth Walk outside in only underwear Repetitively paced in his yard in a particular pattern ROS Dysphagia Bradykinesia Incontinence 68 year-old left-handed man with progressive cognitive impairment MRI T1-Weighted Sequences 15

16 Ancillary Testing MRI Brain: severe L>R atrophy Lateral and medial frontal lobes Anterior and medial temporal lobes PIB-PET: negative Expert Opinion Year 1 Difficulty fixing up cars Interpretation of Imaging? Final Diagnosis and Pathology? Change your mind? Year 2 Year 3 Trouble understanding his wife in conversation Hearing aid no improvement Repeating conversations, word-finding difficulty, substitute/mispronounce words Paucity of speech (down 25%), spoke with softer voice Year 4 Year 5 Progressive difficulty with familiar tasks, stopped driving Speech output down 80%, difficulty expressing himself hand motions No longer pursued hobbies, quit working, needed encouragement to keep up his hygiene Increased sleep, daytime naps Lacked insight, content mood Nearly mute, unable to read or write Excessive eating, weight gain, stuff large amounts of food in his mouth Walk outside in only underwear Repetitively paced in his yard in a particular pattern 68 year-old left-handed man with progressive cognitive impairment 16

17 68 year-old left-handed man with progressive cognitive impairment Pathology Discussion Year 6 Year 7 Marked progression of apathy Decline in mobility and functional independence No longer following commands No longer responding to voice Significant weight loss, feeding tube placement Bedridden Hospice Dr. Grinberg, what are the range of pathological findings that can be seen in a patient presenting with these signs and symptoms? What did the autopsy show? RAIN 2017 CPC Pathology bvftd SD PNFA FTD-MND CBS PSPS Frontotemporal lobar degeneration (FTLD) Lea T. Grinberg, M.D Ph.D Associate Professor of Neurology and Pathology UCSF 17

18 bvftd SD PNFA FTD-MND CBS PSPS bvftd SD PNFA FTD-MND CBS PSPS Frontotemporal lobar degeneration (FTLD) Alzheimer s Disease Frontotemporal lobar degeneration (FTLD) Alzheimer s Disease FTLD-tau FTLD-TDP* FTLD-FUS FTLD-3 (CHMP2b) FTLD-tau FTLD-TDP* FTLD-FUS FTLD-3 (CHMP2b) Pick s 3R tau CBD 4R tau PSP 4R tau Type A (PGRN) (C9orf72) Type B (C9orf72) (TARDP?) aftld-u BIBD Pick s 3R tau CBD 4R tau PSP 4R tau Type A (PGRN) (C9orf72) Type B (C9orf72) (TARDP?) aftld-u BIBD FTDP-17 (MAPT) Tau NOS MST/AGD Type C Type D (VCP) NIFID??? (FUS) FTDP-17 (MAPT) Tau NOS MST/AGD Type C Type D (VCP) NIFID??? (FUS) Courtesy W. Seeley, UCSF *Harmonized scheme Courtesy W. Seeley, UCSF *Harmonized scheme Weight: 1066 g UCSF/MAC Neurodegenerative Disease Brain Bank R 18

19 1. Moderate dorsolateral frontal and insula atrophy 2. Mild ventral frontal and temporal atrophy 3. Caudate is flat 4. Hippocampus is relatively spared 100 µm Example of negative immunohistochemical assay 19

20 Beta-amyloid TDP-43 ITG IFG * SN ITG Scarce number of diffuse and neuritic plaques in the primary visual area (occipital cortex) unclassifiable: neuronal cytoplasmatic and nuclear inclusions, threads, glial inclusions in all cortical layers Scale bars: 10 µm 3R- and 4 Repeat-tau Immunohistochemistry for p62 - cerebellum The signature pathology Atypical neuronal/glial 4R-tauopathy (limbic and peri-limbic RD4 RD3 Entorhinal cortex Scale bars: 10 µm pathognomonic of C9orf72 expansions Ubiquitin IHC, cerebellar granule cells 20

21 Final Neuropathological Diagnoses Primary diagnosis: Frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions FTLD-TDP, unclassifiable Contributing diagnosis : 4-repeat tauopathy, not otherwise specified Incidental diagnosis: Alzheimer s disease neuropathological change (ADNC) 2 Low ADNC, NIA-AA Criteria (A1, B1, C0) Thal Amyloid Plaque Phase 1 Braak Neurofibrillary Degeneration Stage 1 CERAD Neuritic Plaque Score none, Case Summary Our patient developed cognitive impairment in his mid- 60 s that progressed over 7 years Cognitive domains: 1. Executive 2. Behavior + Language Brain Imaging: 1. Anterior-predominant hypometabolism 2. Severe L>R frontal & anterior temporal lobe atrophy Clinical Dx: behavioral-variant Frontotemporal Dementia Pathological Dx: FTLD-TDP associated with mutation in C9ORF72 behavioral-variant Frontotemporal Dementia Epidemiology FTD is 2 nd most common cause of early-onset neurodegenerative dementia (after AD) Prevalence: per 100K persons yo 10% occurs in patients <45 yo 30% occurs in patients >65 yo bvftd accounts for >50% of autopsyconfirmed FTLD Knopman et al, J Mol Neurosci 2011 Snowden et al, Brain

22 Genetics 40% of FTD is associated with autosomal dominant inheritance bvftd & agrammatic PPA are most common phenotypes Mutations in 8 genes account for 50% of familial FTD C9ORF72 mutation is most common genetic abnormality in familial FTD (12%) and familial ALS (23%) Rohrer et al, Neurology 2009 Le Ber, Rev Neurol 2013 DeJesus-Hernandez et al, Neuron 2011 Criteria for bvftd Gradual onset and progressive deterioration of behavior and/or cognition Disinhibition Apathy Ritualistic behavior Hyperorality Frontal and/or anterior temporal pattern on MRI or PET Rascovsky et al, Brain 2011 Management No approved therapies for FTD Supportive care Power of attorney Swallow evaluation Physical therapy Genetic counseling Finger, Continuum

23 Acknowledgements The patient and his family UCSF Memory and Aging Center Discussants: Dr. Gil Rabinovici Dr. Lea Grinberg RAIN 2017 Co-Chairs: Dr. Stephen Hauser Dr. Andy Josephson 23

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology

More information

I do not have any disclosures

I do not have any disclosures Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo

More information

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia

Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease

More information

FTD basics! Etienne de Villers-Sidani, MD!

FTD basics! Etienne de Villers-Sidani, MD! FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant

More information

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology

More information

! slow, progressive, permanent loss of neurologic function.

! slow, progressive, permanent loss of neurologic function. UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation

More information

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features

More information

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota

Dementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function

More information

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION

LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the

More information

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive

More information

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney. I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal

More information

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends

More information

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

Neuro degenerative PET image from FDG, amyloid to Tau

Neuro degenerative PET image from FDG, amyloid to Tau Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging

More information

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer

More information

Frontotemporal dementia:

Frontotemporal dementia: Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins

More information

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries Clinical Differences Among Four Common Dementia Syndromes a program of Morningside Ministries Introduction Four clinical dementia syndromes account for 90% of all cases after excluding reversible causes

More information

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1 Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer

More information

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University DAT: 55-60% VD: 15-20% DLBD: 15-20% FTD:

More information

FRONTO TEMPORAL DEMENTIA

FRONTO TEMPORAL DEMENTIA FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University Fronto-Temporal Lobe Dementia (FTLD) DAT:

More information

Non Alzheimer Dementias

Non Alzheimer Dementias Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009 Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by

More information

Biomarkers: Translating Research into Clinical Practice

Biomarkers: Translating Research into Clinical Practice Biomarkers: Translating Research into Clinical Practice AFTD Education Conference San Diego, April 2015 Nadine Tatton, PhD Scientific Director, AFTD HelpLine 866-5507-7222 u info@theaftd.org u www.theaftd.org

More information

2016 Programs & Information

2016 Programs & Information Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia

More information

Differential Diagnosis of Hypokinetic Movement Disorders

Differential Diagnosis of Hypokinetic Movement Disorders Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease

More information

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)

Clinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following

More information

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias Presenter: Kim Bailey, MS Gerontology, Program & Education Specialist, Alzheimer s Orange County 1 1 Facts About Our

More information

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN Parkinson s Academy Registrar Masterclass Sheffield DIFFERENTIAL DIAGNOSIS SARAH MARRINAN 17 th September 2014 Objectives Importance of age in diagnosis Diagnostic challenges Brain Bank criteria Differential

More information

Dementia Past, Present and Future

Dementia Past, Present and Future Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,

More information

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16 The impact of FDG PET in degenerative dementia diagnosis Jung Lung, Hsu MD, Ph.D (Utrecht) Section of dementia and cognitive impairment Department of Neurology Chang Gung Memorial Hospital, Linkou, Taipei

More information

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies

A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies A Fresh View of Cognitive Disorders in Older Adults: New Classification and Screening Strategies Lynda Mackin, PhD, AGPCNP-BC, CNS University of California San Francisco School of Nursing 1 Alzheimer s

More information

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:

Aging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain: Aging & Cognition Ladan Ghazi Saidi, Ph.D., Assistant Professor, Department of Communication Disorders, COE, University of Nebraska at Kearney 2018 Nebraska Speech-Language-Hearing Association Fall Convention

More information

The Person: Dementia Basics

The Person: Dementia Basics The Person: Dementia Basics Objectives 1. Discuss how expected age related changes in the brain might affect an individual's cognition and functioning 2. Discuss how changes in the brain due to Alzheimer

More information

SECTION 1: as each other, or as me. THE BRAIN AND DEMENTIA. C. Boden *

SECTION 1: as each other, or as me. THE BRAIN AND DEMENTIA. C. Boden * I read all the available books by other [people with] Alzheimer s disease but they never had quite the same problems as each other, or as me. I t s not like other diseases, where there is a standard set

More information

FDG-PET e parkinsonismi

FDG-PET e parkinsonismi Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism

More information

High Yield Neurological Examination

High Yield Neurological Examination High Yield Neurological Examination Vanja Douglas, MD Sara & Evan Williams Foundation Endowed Neurohospitalist Chair Director, Neurohospitalist Division Associate Professor of Clinical Neurology UCSF Department

More information

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2 The th Annual Memory Clinic Conference Dublin, Trinity College, 27 March 1 The structure of the talk Dementia as a motor disorder Thomas H. Bak Human Cognitive Neuroscience & Centre for Clinical Brain

More information

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter For carers and relatives of people with frontotemporal dementia and semantic dementia Newsletter AUGUST 2008 1 Welcome Welcome to the August edition of our CFU Support Group Newsletter. Thanks to all of

More information

Overview of the non-alzheimer Dementias

Overview of the non-alzheimer Dementias Overview of the non-alzheimer Dementias Chiadi U. Onyike, MD, MHS FTD/Young-Onset Dementias Program Johns Hopkins Neuropsychiatry Disclaimer Dr. Onyike is a principal investigator for the Baltimore site

More information

The motor regulator. 2) The cerebellum

The motor regulator. 2) The cerebellum The motor regulator 2) The cerebellum Motor control systems outside the cortex Cerebellum -controls neural programs for the executionl of skilled movements Cerebellar Peduncles Atlas Fig. 2-31 Atlas Fig.

More information

Prof Tim Anderson. Neurologist University of Otago Christchurch

Prof Tim Anderson. Neurologist University of Otago Christchurch Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral

More information

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,

More information

Dementia and Healthy Ageing : is the pathology any different?

Dementia and Healthy Ageing : is the pathology any different? Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association

More information

Title: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID)

Title: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID) Neurology/2004/048785 Title: Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease (NIFID) Correspondence to: Nigel J. Cairns PhD MRCPath Center for Neurodegenerative

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion

3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia

More information

III./3.1. Movement disorders with akinetic rigid symptoms

III./3.1. Movement disorders with akinetic rigid symptoms III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.

More information

The ABCs of Dementia Diagnosis

The ABCs of Dementia Diagnosis The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What

More information

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language

More information

The High-Yield Neurologic Examination

The High-Yield Neurologic Examination The High-Yield Neurologic Examination S. Andrew Josephson MD Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Chair, Department of Neurology Director, Neurohospitalist

More information

The Neurologic Examination: High-Yield Strategies

The Neurologic Examination: High-Yield Strategies The Neurologic Examination: High-Yield Strategies S. Andrew Josephson, MD Examination Approach Two types of neurologic examinations 1. Screening Examination 2. Testing Hypotheses Select high-yield tests

More information

Common Forms of Dementia Handout Package

Common Forms of Dementia Handout Package Common Forms of Dementia Handout Package Common Forms of Dementia 1 Learning Objectives As a result of working through this module, you should be better able to: 1. Describe clinical features of 4 major

More information

Diagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology

Diagnosis and management of non-alzheimer dementias. Melissa Yu, M.D. Department of Neurology Diagnosis and management of non-alzheimer dementias Melissa Yu, M.D. Department of Neurology AGENDA Introduction When to think of alternate diagnoses Other forms of dementia Other reasons for confusion

More information

Molecular Imaging Heterogeneity of Clinically Defined AD

Molecular Imaging Heterogeneity of Clinically Defined AD Molecular Imaging Heterogeneity of Clinically Defined AD Gil Rabinovici, M.D. Edward Fein & Pearl Landrith Endowed Professor UCSF Memory & Aging Center 2017 Spring ADC Meeting Boston, MA April 22, 2017

More information

FTD: Improving Outcomes & Outreach

FTD: Improving Outcomes & Outreach 2nd Annual Frontotemporal Degeneration Caregiver Education Conference Raleigh, NC 7.25.12 FTD: Improving Outcomes & Outreach Dan Kaufer, MD Associate Professor, Neurology Director, Memory Disorders Program

More information

The Neurologic Examination: High-Yield Strategies

The Neurologic Examination: High-Yield Strategies The Neurologic Examination: High-Yield Strategies S. Andrew Josephson, MD Assistant Professor, Department of Neurology Divisions of Neurovascular and Behavioral Neurology University of California San Francisco

More information

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient DEMENTIA WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient Progressive and disabling Not an inherent aspect of

More information

Clinical Genetics & Dementia

Clinical Genetics & Dementia Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history

More information

Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step?

Dementia and Delirium: A Neurologist s Approach to Altered Mental Status. Case 1 4/7/11. Which of the following evaluations is your next step? Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson, MD Director, Neurohospitalist Program Medical Director, Inpatient Neurology University of California San Francisco

More information

Navigating The Cognitive Internet: Introduction. Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System

Navigating The Cognitive Internet: Introduction. Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System Navigating The Cognitive Internet: Introduction Wendy Lemere DNP, GNP-BC Gerontological Nurse Practitioner Henry Ford Health System What s so hard about diagnosing dementia? Diagnosis relies on synthesis

More information

Phenotypic Variability in ALS

Phenotypic Variability in ALS Phenotypic Variability in ALS Michael A. Elliott, MD, FAAN Medical Director, ALS Clinic Swedish Neuroscience Institute 1 Outline ALS Background Description Typical Presentation Clinical Phenotype Motor

More information

P20.2. Characteristics of different types of dementia and challenges for the clinician

P20.2. Characteristics of different types of dementia and challenges for the clinician P20.2. Characteristics of different types of dementia and challenges for the clinician, professor Danish Dementia Research Center Rigshospitalet, University of Copenhagen (Denmark) This project has received

More information

Objectives. Overview. Why FTD and AD? FTD May Mimic AD. Introduction and Process Norman L. Foster, MD. Introduction and Process 7BS.

Objectives. Overview. Why FTD and AD? FTD May Mimic AD. Introduction and Process Norman L. Foster, MD. Introduction and Process 7BS. Introduction and Process Norman L. Foster, MD 7BS.006 IMPROVING ACCURACY OF DEMENTIA DIAGNOSIS: CASE STUDIES WITH NEUROPATHOLOGY Norman L. Foster, MD University of Utah Salt Lake City, UT Edward Zamrini,

More information

review of existing studies on ASL in dementia Marion Smits, MD PhD

review of existing studies on ASL in dementia Marion Smits, MD PhD review of existing studies on ASL in dementia Marion Smits, MD PhD Associate Professor of Neuroradiology Department of Radiology, Erasmus MC, Rotterdam (NL) Alzheimer Centre South-West Netherlands, Rotterdam

More information

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1

Brain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1 Brain Advance Access published February 25, 2014 doi:10.1093/brain/awu024 Brain 2014: Page 1 of 17 1 BRAIN A JOURNAL OF NEUROLOGY Asymmetry and heterogeneity of Alzheimer s and frontotemporal pathology

More information

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14. NIH Public Access Author Manuscript Published in final edited form as: Semin Neurol. 2013 September ; 33(4): 386 416. doi:10.1055/s-0033-1359312. Neuroimaging Biomarkers of Neurodegenerative Diseases and

More information

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits

More information

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center Diffusion Tensor Imaging in Dementia Howard Rosen UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu Overview Examples of DTI findings in Alzheimer s disease And other dementias Explore

More information

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia Dementia: A Comprehensive Update 2016 Neuroimaging, CSF, and genetic biomarkers in dementia Bradford C. Dickerson, M.D. Associate Professor of Neurology, Harvard Medical School Departments of Neurology

More information

Differential Diagnosis

Differential Diagnosis Differential Diagnosis 2 2.1 Introduction AD accounts for up to 75 % of all dementia cases. The differential diagnosis with other conditions is sometimes challenging since several disorders may produce

More information

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration

More information

Dementia and Alzheimer s disease

Dementia and Alzheimer s disease Since 1960 Medicine Korat โรงพยาบาลมหาราชนครราชส มา Dementia and Alzheimer s disease Concise Reviews PAWUT MEKAWICHAI MD DEPARTMENT of MEDICINE MAHARAT NAKHON RATCHASIMA HOSPITAL 1 Prevalence Increase

More information

Diagnosis and Treatment of Alzhiemer s Disease

Diagnosis and Treatment of Alzhiemer s Disease Diagnosis and Treatment of Alzhiemer s Disease Roy Yaari, MD, MAS Director, Memory Disorders Clinic, Banner Alzheimer s Institute 602-839-6900 Outline Introduction Alzheimer s disease (AD)Guidelines -revised

More information

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce

Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce ALESSANDRO MARTORANA UOC NEUROLOGIA-CENTRO ALZHEIMER POLICLINICO TOR VERGATA-UNIVERSITÀ DI ROMA TOR VERGATA

More information

Assessing and Managing the Patient with Cognitive Decline

Assessing and Managing the Patient with Cognitive Decline Assessing and Managing the Patient with Cognitive Decline Center of Excellence For Alzheimer s Disease for State of NY Capital Region Alzheimer s Center of Albany Medical Center Earl A. Zimmerman, MD Professor

More information

Dementia. Assessing Brain Damage. Mental Status Examination

Dementia. Assessing Brain Damage. Mental Status Examination Dementia Assessing Brain Damage Mental status examination Information about current behavior and thought including orientation to reality, memory, and ability to follow instructions Neuropsychological

More information

The motor regulator. 2) The cerebellum

The motor regulator. 2) The cerebellum The motor regulator 2) The cerebellum Motor control systems outside the cortex Cerebellum -controls neural programs for the executionl of skilled movements Feed-back and feed-forward control circuits By

More information

Overview of neurological changes in Alzheimer s disease. Eric Karran

Overview of neurological changes in Alzheimer s disease. Eric Karran Overview of neurological changes in Alzheimer s disease Eric Karran Alzheimer s disease Alois Alzheimer 1864-1915 Auguste D. 1850-1906 Case presented November 26 th 1906 Guildford Talk.ppt 20 th March,

More information

Cerebral Cortex Structure, Function, Dysfunction Reading Ch 10 Waxman Dental Neuroanatomy Lecture. Suzanne Stensaas, Ph.D.

Cerebral Cortex Structure, Function, Dysfunction Reading Ch 10 Waxman Dental Neuroanatomy Lecture. Suzanne Stensaas, Ph.D. Cerebral Cortex Structure, Function, Dysfunction Reading Ch 10 Waxman Dental Neuroanatomy Lecture Suzanne Stensaas, Ph.D. March 7, 2012 Anatomy Review Lobes and layers Brodmann s areas Vascular Supply

More information

Stroke School for Internists Part 1

Stroke School for Internists Part 1 Stroke School for Internists Part 1 November 4, 2017 Dr. Albert Jin Dr. Gurpreet Jaswal Disclosures I receive a stipend for my role as Medical Director of the Stroke Network of SEO I have no commercial

More information

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY

AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY Professor Tim Lynch Dublin Neurological Institute at the Mater Misericordiae University Hospital University College Dublin Dublin, IRELAND This Case-based

More information

A Hypothesis Driven Approach to the Neurological Exam

A Hypothesis Driven Approach to the Neurological Exam A Hypothesis Driven Approach to the Neurological Exam Vanja Douglas, MD Assistant Clinical Professor UCSF Department of Neurology Disclosures None 1 Purpose of Neuro Exam Screen asymptomatic patients Screen

More information

The Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch.

The Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch. The Frontal Lobes Readings: KW Ch. 16 Portrait: Losing Frontal-Lobe Functions E.L. Highly organized college professor Became disorganized, showed little emotion, and began to miss deadlines Scores on intelligence

More information

Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology

Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology Activity Everyone stand up, raise your right hand, tell your neighbors your name 1 What part of the brain

More information

DEMENTIA ANDREA BERG, MD

DEMENTIA ANDREA BERG, MD DEMENTIA ANDREA BERG, MD What Is Dementia? Decline in memory, language, problem-solving and other cognitive skills that affects a persons ability to perform everyday activities Progressive and disabling

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Devenney E, Bartley L, Hoon C, et al. Progression in behavioral variant frontotemporal dementia: a longitudinal study. JAMA Neurol. Published online October 26, 2015. doi:10.1001/jamaneurol.2015.2061.

More information

Lecture 42: Final Review. Martin Wessendorf, Ph.D.

Lecture 42: Final Review. Martin Wessendorf, Ph.D. Lecture 42: Final Review Martin Wessendorf, Ph.D. Lecture 33 cortex Heilbronner 5 lobes of the cortex Lateral view (left side) Mid-saggital view (right side) Cellular organization of cortex White matter

More information

UDS version 3 Summary of major changes to UDS form packets

UDS version 3 Summary of major changes to UDS form packets UDS version 3 Summary of major changes to UDS form packets from version 2 to VERSION 3 february 18 final Form A1: Subject demographics Updated question on principal referral source to add additional options

More information

Confronting the Clinical Challenges of Frontotemporal Dementia

Confronting the Clinical Challenges of Frontotemporal Dementia Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask

More information

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea

Department of Neurology, Kangwon National University Hospital, Chuncheon, Korea Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2015;14(2):87-93 / http://dx.doi.org/10.12779/dnd.2015.14.2.87 CASE REPORT DND Longitudinal Clinical Changes of Non-Fluent/Agrammatic

More information

FTD/PPA Caregiver Education Conference March 11, 2011

FTD/PPA Caregiver Education Conference March 11, 2011 FTD/PPA Caregiver Education Conference March 11, 2011 Question and Answer Session Answered by Joseph Cooper, MD, Darby Morhardt, MSW, LCSW, Mary O Hara, AM, LCSW, Jaimie Robinson, MSW, LCSW, Emily Rogalski,

More information

doi: /brain/awr198 Brain 2011: 134;

doi: /brain/awr198 Brain 2011: 134; doi:10.1093/brain/awr198 Brain 2011: 134; 2565 2581 2565 BRAIN A JOURNAL OF NEUROLOGY Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Jonathan D. Rohrer,

More information

A Case of Vascular MCI

A Case of Vascular MCI A Case of Vascular MCI Charles DeCarli, MD Victor and Genevieve Orsi Chair in Alzheimer s Research Director Alzheimer s Disease Center University of California at Davis Initial Evaluation 78 y.o. Rt. Handed

More information

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology

Dementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology Dementia Amber Eker, MD Assistant Professor Near East University Department of Neurology Dementia An acquired syndrome consisting of a decline in memory and other cognitive functions Impairment in social

More information

Imaging of Alzheimer s Disease: State of the Art

Imaging of Alzheimer s Disease: State of the Art July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression

More information

Dementia and Aphasia-AD, FTD & aphasia

Dementia and Aphasia-AD, FTD & aphasia 特別講演 Dementia and Aphasia-AD, FTD & aphasia Shunichiro Shinagawa, Bruce L. Miller Key words : Alzheimer s disease, frontotemporal dementia, primary progressive aphasia Alzheimer s disease(ad)and frontotemporal

More information

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California

NCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California The National Cell Repository for Alzheimer s Disease (NCRAD) is a data and specimen collection source for families with Alzheimer disease (AD) or serious memory loss. Families having two or more living

More information